Microwave assisted solubilization of inclusion bodies
© Datta et al.; licensee Chemistry Central Ltd. 2013
Received: 14 January 2013
Accepted: 26 March 2013
Published: 22 May 2013
Production of recombinant proteins in bacterial hosts often produces insoluble intracellular particles called inclusion bodies. Recovery of active protein from inclusion bodies generally requires their solubilization in chemical denaturants followed by a refolding strategy. The solubilization is carried out with shaking/stirring and takes several hours.
Using inclusion bodies of seven diverse kinds of recombinant proteins [mutants of controller of cell division or death protein B (CcdB), human CD4D12, thioredoxin fusion protein (malETrx), mutants of maltose binding protein (MBP), single chain variable fragment (ScFv) b12 and single chain antigen binding fragment (ScFab) b12 (anti-HIV-1)], it is shown that exposure to microwave irradiation (200 W) for 2 min, solubilized these inclusion bodies completely. This was confirmed by data based upon turbidity measurements at 400 nm and dynamic light scattering studies. These solubilized inclusion bodies could be refolded correctly in all the cases by known methods. The refolding was confirmed by fluorescence emission spectra and biological activity studies.
Solubilization of the inclusion bodies before refolding is a part of protein production processes for several recombinant proteins which are overexpressed in the bacterial host systems. Our results show that microwave assistance can considerably shorten the process time.
KeywordsSolubilization of inclusion bodies Protein refolding Microwave assisted reactions Maltose binding protein Thioredoxin
Production of recombinant proteins in bacterial hosts often produces insoluble particles called “inclusion bodies” [1–3]. Recovery of active soluble proteins from these inclusion bodies involves two steps. The first step is the solubilization of the inclusion bodies which involves unfolding of the protein molecules by chemical denaturants  and the second step is the refolding step. No single refolding method is universally applicable and hence a large number of strategies have been described in the literature for refolding purposes [2, 5–8]. The innovations in the first step have been rather limited . Urea and Guanidinium hydrochloride (GuHCl) are the most frequently employed denaturants [10, 11]. Some surfactants like cetyltrimethylammonium bromide (CTAB) and sodium dodecyl sulfate (SDS) have been also tried [11–13]. Use of cetyltrimethylammonium chloride (CTAC) has been reported to improve subsequent yields of the refolded proteins .
The solubilization step generally requires from 1 to 80 hours  and hence constitutes a significant component of process time for production of recombinant proteins . The present work outlines a simple, efficient and fast solubilization procedure. The strategy involves microwave assisted solubilization and takes only 2 minutes.
Microwave assistance is known to facilitate numerous chemical reactions , biochemical reactions [17–19], biochemical conjugation [20, 21] and protein degradation in proteomics [19, 20]. Its application for facilitating rapid solubilization of inclusion bodies does not seem to have been described so far. It is shown that the method works well with inclusion bodies of several diverse kinds of recombinant proteins. It is also shown that the refolded proteins obtained from microwave assisted solubilized inclusion bodies are structurally identical to refolded proteins obtained after conventional and longer solubilization steps. The refolded proteins have been characterized by fluorescence emission spectra and biological activity assays.
Results and discussion
The inclusion bodies of MBP224D, MBP264D, CcdB-M97K, malETrx, ScFv b12, ScFab b12, and CD4D12 were used for the development of this method. The properties and refolding of these recombinant proteins by a simple precipitation method have been described recently . These chosen proteins were of diverse nature in terms of size, number of disulfide bridges, proneness to aggregation etc. and hence constitute a good representative selection for testing the generic nature of the microwave assisted solubilization method as well.
It may be noted that even though the inclusion bodies appeared to have become completely soluble, the turbidity measurements after solubilization (Figure 1) still had some finite values. This result is in agreement with the one reported by Vincentelli  with a solubilized protein in 6 M GuHCl.
However, no explanation was offered presumably since the turbidity value was considered insignificant. We decided to investigate this further so as to be sure that the microwave treatment is resulting in complete solubilization of the inclusion bodies.
Average sizes of different denaturants
Average diameter (nm) before microwave treatment
Average diameter (nm) after microwave treatment
8 M urea
6 M GuHCl
20 mM SDS
Effect of microwave treatment on the average sizes of different inclusion bodies dissolved in different denaturants
Average diameter (nm) of inclusion bodies in buffer before microwave treatment
Average diameter (nm) after microwave treatment.
8 M urea
6 M GuHCl
20 mM SDS
Insulin aggregation assay for thioredoxin proteins
Specific-Activity (Units mg-1)
Initial protein taken for refolding (solubilized inclusion bodies)
Affinity precipitation refolded malETrx
Ampicillin, isopropyl-β-D-thiogalactopyranoside (IPTG), phenylmethanesulfonylfluoride (PMSF) and guanidinium hydrochloride (GuHCl) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ethylenediaminetetraacetic acid (EDTA) and sodium dodecyl sulfate (SDS) were obtained from Merck (Mumbai, India). Urea (PlusOne grade) was a product of GE Healthcare (Uppsala, Sweden). All other reagents used were of analytical grade.
Over-expression of proteins in E.coli and isolation of inclusion bodies 
E. coli BL21 (DE3) was used for protein expression of malETrx, human CD4D12, mutants of MBP, ScFv b12 and ScFab b12. E. coli CSH501 was used for expressing the CcdB mutant. The plasmids used for expression of these proteins were pBAD24 containing CcdB-M97K, MBP224D and MBP264D inserts, pET20b(+) containing (A14E)malETrx insert, pET28a containing human CD4D12 insert, pET22b(+) containing ScFv b12 insert and pComb containing ScFab b12 insert. The plasmid pBAD24 expressing CcdB mutant M97K was transformed into E. coli CSH501 . A single colony was picked and inoculated into 5 mL LB medium containing 100 μg mL−1 ampicillin. One percent of primary inoculum was transferred into 1 L fresh LB broth (amp+) and grown at 37°C with shaking at 200 rpm until absorbance at 600 nm reached 0.8 and then the induction was carried out. This procedure was repeated for the transformation of the plasmid pET20b(+) containing (A14E) malETrx insert (showing leaky expression), pBAD24 containing MBP224D and 264D inserts, pET22b(+) containing ScFv b12 insert and pComb containing ScFab b12 insert into E. coli BL21 (DE3). The plasmid pET28a expressing CD4D12 was transformed into E. coli BL21 (DE3) and 50 μg mL−1 kanamycin was used as the selection marker. Induction was carried out by adding L-arabinose (0.2%) in case of CcdB-M97K, MBP224D and MBP264D; 0.5 mM IPTG (final concentration) in case of malETrx and CD4D12; and 1 mM IPTG (final concentration) in case of ScFv b12 and ScFab b12, and the culture was further grown under similar conditions for 12 hours at 37°C with shaking at 200 rpm. Cells were harvested, sonicated in resuspension buffer (for CcdB mutant, 50 mM Tris–HCl, pH 8.0/1 mM EDTA/10% glycerol/200 μM PMSF; for malETrx, MBP mutants, ScFv b12 and ScFab b12, 50 mM Tris–HCl, pH 7.0/150 mM NaCl/1 mM EDTA/100 μM PMSF; for CD4D12, 50 mM PBS, pH 7.4/100 μM PMSF) 10 times with 30 seconds pulses on ice, and centrifuged at 9000 × g for 30 minutes at 4°C. The inclusion body pellet was washed (thrice) with washing buffer (50 mM PBS, pH 7.4/0.5% Triton X-100) and centrifuged at 9000 × g for 30 minutes at 4°C.
Inclusion bodies solubilization with microwave
The inclusion bodies of MBP224D, MBP264D CcdB-M97K, CD4D12, malETrx, ScFv and ScFab were suspended in solutions of different denaturants (which included 8 M urea, 6 M GuHCl and 20 mM SDS) in 50 mM Tris–HCl, pH 7.0 in a final volume of 3 mL in an open glass vial and microwave treatment was carried out by placing the reaction mixture inside a domestic microwave oven (Model: NN-K543WF, Panasonic) along with a glass beaker containing 100 ml of water. This was done to avoid overheating of samples. To maintain the temperature, the samples were exposed for 10 seconds in a microwave and then kept outside for 10 seconds in an ice bath. The reaction mixture was exposed to microwave radiations at low power (200 W) with temperature maintained between 25 and 30°C.
The turbidity at 400 nm was measured by Beckman Coulter DU730 spectrophotometer .
Dynamic light scattering (DLS) measurements
Dynamic light scattering measurements were performed at 25°C in laser-spectroscatter 201 by RiNA GmbH (Berlin, Germany). Data analysis was done using PMgr v3.01p17 software supplied with the instrument. The average diameter of the suspension of inclusion bodies was recorded before and after solubilization. The solubilization was carried out both by microwave irradiation for 2 minutes and conventional procedure which consisted of suspending the inclusion bodies in 8 M urea and incubating these at 25°C on a shaker at 200 rpm for 24 hours .
Estimation of protein concentration
The protein concentration in all the cases was estimated by the dye binding method using bovine serum albumin as the standard protein .
Fluorescence spectra of the refolded proteins were recorded on a Cary Eclipse, Varian spectrofluorimeter (Mulgrave, Australia) at 25°C using a 1-cm cuvette. Typically, 0.5-1.0 μM protein in 10 mM Tris–HCl, pH 7.5, was used and the fluorescence emission spectra were recorded from 300 nm to 400 nm upon excitation at 280 nm. The excitation and emission slit widths were kept at 2 nm and 5 nm, respectively. All fluorescence spectra were normalized and corrected for buffer contributions.
Assay for thioredoxin
The activity of thioredoxin was assayed by the insulin aggregation assay .
Binding assay for MBP
The binding of maltose to MBP was assayed fluorimetrically by observing a red shift and quenching in the intrinsic tryptophan of MBP upon maltose binding .
Images were taken on a light microscope (Model: CX21i, Olympus) microscope with an Olympus camera attached to the microscope. The samples were viewed under 1000X magnification (100X objective lens and 10X eye piece) which was obtained by using immersion oil.
Refolding of solubilized inclusion bodies
The solubilized inclusion bodies were refolded by using smart polymers as described previously . The essential steps were as follows:
Different aliquots of solubilized inclusion bodies were incubated with 0.2 mL of 2% (w/v) Eudragit L-100 (final concentration, 0.2%, w/v) for CcdB-M97K and malETrx and 0.3 mL of 2% (w/v) cationic starch (final concentration, 0.3%, w/v) for MBP264D, and the final volume was made up to 2 mL with 50 mM Tris–HCl, pH 7.5. The final protein concentration was 0.2-2.5 mg.mL-1. After incubation at 25°C for 1 hour with shaking at 200 rpm, the polymer-protein complex was precipitated by lowering the pH to 4.0 with 2 M acetic acid in case of Eudragit L-100 and by the addition of 10% (w/v) PEG and 50 mM CaCl2 [stock solutions of PEG (40%, w/v) and CaCl2 (1 M) were made in distilled water] for cationic starch. The precipitate was separated from the unbound protein in the supernatant by centrifugation (10000× g, 10 minutes) at room temperature. The precipitate was then washed twice with 0.01 M acetate buffer, pH 4.0 for Eudragit L-100 and 50 mM Tris–HCl, pH 7.5 for cationic starch. The bound protein was dissociated from the polymer by suspending the polymer-protein complex in 70% (v/v) ethylene glycol solution made in 50 mM Tris–HCl, pH 7.5 for Eudragit L-100 and chilled 1 M NaCl (in 50 mM Tris–HCl, pH 7.5) for cationic starch and incubating at 4°C for 1 hour with shaking at 150 rpm. The supernatant collected after centrifugation at 10000× g for 10 minutes at 4°C, was used for spectroscopic measurements and activity assays. All measurements were carried out after removal of the dissociating agent by membrane filtration (Amicon Ultra-15 3K, Millipore).
Microwave irradiations cause continuous realignment of the polar molecules with the changing field. This causes solutions containing polar molecules (such as water) to get heated. However, as opposed to simple heating, the energy input is more efficient and happens over a shorter period of time. Hence, many workers describe such effects as “non-thermal effects” of the microwave irradiations. Hence, exposure to microwave irradiations is known to accelerate many processes [16, 17].
The results obtained with seven inclusion bodies of diverse kinds of proteins show that a minimum exposure to microwave radiation for just 2 minutes is enough to solubilize inclusion bodies irrespective of which of the commonly used denaturants is used. These results have been obtained with a commonly available ordinary domestic microwave oven. Such microwave ovens are available in all biochemistry laboratories. Wherever available, a microwave with a temperature control can also be utilized. The results further indicate the method described here did not merely solubilize the inclusion bodies but led to unfolded protein molecules which could be refolded just as well as those obtained by existing procedures which require longer duration of time. Production of many industrially important proteins (including pharmaceutical proteins) requires solubilization of inclusion bodies followed by a refolding step. The method outlined here would make the whole process shorter and possibly more economical. As much as the use of microwave in case of conventional methods is considered a strong component of green chemistry, the method described here can be considered as a part of initiative to develop greener production processes .
We acknowledge financial support provided by Department of Biotechnology (DBT) [Grant number: BT/PR14103/BRB/10/808/2010] and Department of Science and Technology (DST), Government of India. Financial support provided by Council of Scientific and Industrial Research to SG in the form of senior Research Fellowship is also gratefully acknowledged. We also thank Professor Raghavan Varadarajan (Indian Institute of Science, Bangalore) for providing the clones of MBP224D, MBP264D, CcdB-M97K, malETrx, ScFv b12, ScFab b12, and CD4D12.
- Walker SG, Lyddiatt A: Aqueous two-phase systems as an alternative process route for the fractionation of small inclusion bodies. J Chromatogr B. 1998, 711: 185-194. 10.1016/S0378-4347(97)00604-X.View Article
- Middelberg APJ: Preparative protein refolding. Trends Biotechnol. 2002, 20: 437-443. 10.1016/S0167-7799(02)02047-4.View Article
- Upadhyay AK, Murmu A, Singh A, Panda AK: Kinetics of Inclusion Body Formation and Its Correlation with the Characteristics of Protein Aggregates in Escherichia coli. PLoS One. 2012, 7 (3): e33951-10.1371/journal.pone.0033951.View Article
- Vallejo LF, Rinas U: Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact. 2004, 3: 11-10.1186/1475-2859-3-11.View Article
- Cleland JL, Builder SE, Swartz JR, Winkler M, Chang JY, Wang DI: Polyethylene glycol enhanced protein refolding. Biotechnology NY. 1992, 10: 1013-1019. 10.1038/nbt0992-1013.View Article
- Basu A, Li X, Leong SS: Refolding of proteins from inclusion bodies: rational design and recipes. Appl Microbiol Biotechnol. 2011, 92: 241-251. 10.1007/s00253-011-3513-y.View Article
- Gautam S, Dubey P, Singh P, Kesavardhana S, Varadarajan R, Gupta MN: Smart polymer mediated purification and recovery of active proteins from inclusion bodies. J Chromatogr A. 2012, 1235: 10-25.View Article
- Burgess RR: Refolding solubilized inclusion body proteins. Methods Enzymol. 2009, 463: 259-282.View Article
- Singh SM, Panda AK: Solubilization and refolding of bacterial inclusion body proteins. J Biosci Bioeng. 2005, 99: 303-310. 10.1263/jbb.99.303.View Article
- Marston FA, Hartley DL: Solubilization of protein aggregates. Methods Enzymol. 1990, 182: 264-276.View Article
- Hamada H, Arakawa T, Shiraki K: Effect of additives on protein aggregation. Curr Pharm Biotechnol. 2009, 10: 400-407. 10.2174/138920109788488941.View Article
- Stöckel J, Döring K, Malotka J, Jähnig F, Dornmair K: Pathway of detergent-mediated and peptide ligand-mediated refolding of heterodimeric class II major histocompatibility complex (MHC) molecules. Eur J Biochem. 1997, 248: 684-691. 10.1111/j.1432-1033.1997.t01-2-00684.x.View Article
- Sarramegna V, Muller I, Mousseau G, Froment C, Monsarrat B, Milon A, Talmont F: Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris. Protein Expr Purif. 2005, 43: 85-93. 10.1016/j.pep.2005.05.007.View Article
- Puri NK, Crivelli E, Cardamone M, Fiddes R, Bertolini J, Ninham B, Brandon MR: Solubilization of growth hormone and other recombinant proteins from Escherichia coli inclusion bodies by using a cationic surfactant. Biochem J. 1992, 285: 871-879.View Article
- Fischer B, Sumner I, Goodenough P: Isolation, renaturation, and formation of disulfide bonds of eukaryotic proteins expressed in Escherichia coli as inclusion bodies. Biotechnol Bioeng. 1993, 41: 3-13. 10.1002/bit.260410103.View Article
- Polshettiwar V, Varma RS: Microwave-assisted organic synthesis and transformations using benign reaction media. Acc Chem Res. 2008, 41: 629-639. 10.1021/ar700238s.View Article
- Roy I, Gupta MN: Applications of microwaves in biological sciences. Curr Sci. 2003, 80: 1685-1693.
- Roy I, Gupta MN: Non thermal effects of microwaves on protease catalyzed esterification and trans-esterification. Tetrahedron. 2003, 59: 5431-5436. 10.1016/S0040-4020(03)00867-6.View Article
- Loupy A, Varma RS: Microwave effects in organic synthesis: Mechanistic and reaction medium considerations. Chem Inform. 2007, 38:
- Hayes BL: Microwave synthesis chemistry at the speed of light. 2002, NC: CEM Publishing
- Solanki K, Mondal K, Gupta MN: Microwave-assisted preparation of affinity medium. Anal Biochem. 2007, 360: 123-129. 10.1016/j.ab.2006.09.029.View Article
- Vincentelli R, Canaan S, Campanacci V, Valencia C, Maurin D, Frassinetti F, Scappucini-Calvo L, Bourne Y, Cambillau C, Bignon C: High-throughput automated refolding screening of inclusion bodies. Protein Sci. 2004, 13: 2782-2792.View Article
- Sokolic F, Idrissi A, Perera A: Concentrated aqueous urea solutions: A molecular dynamics study of different models. J Chem Phys. 2002, 116: 1636-1646. 10.1063/1.1429958.View Article
- Mason PE, Neilson GW, Enderby JE, Saboungi ML, Dempsey CE, MacKerell AD, Brady JW: The structure of aqueous guanidinium chloride solutions. J Am Chem Soc. 2004, 126: 11462-11470. 10.1021/ja040034x.View Article
- O'Brien EP, Dima RI, Brooks B, Thirumalai D: Interactions between hydrophobic and ionic solutes in aqueous guanidinium chloride and urea solutions: lessons for protein denaturation mechanism. J Am Chem Soc. 2007, 129: 7346-7353. 10.1021/ja069232+.View Article
- Stumpe MC, Grubmüller H: Aqueous urea solutions: structure, energetics, and urea aggregation. J Phys Chem B. 2007, 111: 6220-6228. 10.1021/jp066474n.View Article
- Szmelcman S, Schwartz M, Silhavy TJ, Boos W: Maltose transport in Escherichia coli K12. A comparison of transport kinetics in wild-type and lambda-resistant mutants as measured by fluorescence quenching. Eur J Biochem. 1976, 65: 13-19. 10.1111/j.1432-1033.1976.tb10383.x.View Article
- Chakshusmathi G, Mondal K, Lakshmi GS, Singh G, Roy A, Ch RB, Madhusudhanan S, Varadarajan R: Design of temperature-sensitive mutants solely from amino acid sequence. Proc Natl Acad Sci U S A. 2004, 101: 7925-7930. 10.1073/pnas.0402222101.View Article
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016/0003-2697(76)90527-3.View Article
- Holmgren A: Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J Biol Chem. 1979, 254: 9627-9632.
- Ulber R: White Biotechnology. Sell: Advances in biochemical engineering/Biotechnology Volume 105. 2007, Heidelberg: Springer
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.